Palladium Partners LLC boosted its position in Clorox Co (NYSE:CLX) by 32.4% in the 4th quarter, HoldingsChannel reports. The firm owned 2,255 shares of the company’s stock after buying an additional 552 shares during the period. Palladium Partners LLC’s holdings in Clorox were worth $335,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CLX. Moors & Cabot Inc. grew its position in shares of Clorox by 1.2% in the second quarter. Moors & Cabot Inc. now owns 2,557 shares of the company’s stock valued at $339,000 after purchasing an additional 30 shares during the period. WFG Advisors LP grew its position in shares of Clorox by 7.2% in the second quarter. WFG Advisors LP now owns 1,571 shares of the company’s stock valued at $209,000 after purchasing an additional 106 shares during the period. Cetera Investment Advisers grew its position in shares of Clorox by 17.9% in the second quarter. Cetera Investment Advisers now owns 2,627 shares of the company’s stock valued at $348,000 after purchasing an additional 399 shares during the period. Stock Yards Bank & Trust Co. grew its position in shares of Clorox by 8.4% in the third quarter. Stock Yards Bank & Trust Co. now owns 5,172 shares of the company’s stock valued at $683,000 after purchasing an additional 400 shares during the period. Finally, Pinkerton Retirement Specialists LLC grew its position in shares of Clorox by 2.2% in the third quarter. Pinkerton Retirement Specialists LLC now owns 18,387 shares of the company’s stock valued at $2,387,000 after purchasing an additional 401 shares during the period. 73.68% of the stock is owned by hedge funds and other institutional investors.

In other Clorox news, SVP Michael R. Costello sold 10,574 shares of the business’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the transaction, the senior vice president now owns 34,867 shares in the company, valued at $4,742,260.67. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 1.00% of the company’s stock.

A number of brokerages have recently commented on CLX. Jefferies Group reaffirmed a “hold” rating and issued a $130.00 price objective on shares of Clorox in a research report on Wednesday, December 13th. Wells Fargo & Co reaffirmed a “hold” rating and issued a $130.00 price objective on shares of Clorox in a research report on Wednesday, December 13th. Deutsche Bank began coverage on Clorox in a research report on Wednesday, December 13th. They issued a “hold” rating and a $142.00 price objective for the company. Zacks Investment Research raised Clorox from a “hold” rating to a “buy” rating and set a $163.00 price objective for the company in a research report on Monday, January 8th. Finally, Bank of America upgraded Clorox from an “underperform” rating to a “neutral” rating and set a $155.00 target price on the stock in a report on Thursday, January 4th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $132.26.

Clorox Co (NYSE CLX) opened at $130.63 on Wednesday. The company has a market capitalization of $16,434.31, a PE ratio of 21.56, a price-to-earnings-growth ratio of 3.11 and a beta of 0.31. Clorox Co has a one year low of $123.58 and a one year high of $150.40. The company has a debt-to-equity ratio of 2.35, a quick ratio of 0.86 and a current ratio of 1.22.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Friday, February 2nd. The company reported $1.23 EPS for the quarter, topping the Zacks’ consensus estimate of $1.22 by $0.01. The company had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.43 billion. Clorox had a return on equity of 126.70% and a net margin of 13.21%. The firm’s quarterly revenue was up .7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.14 earnings per share. sell-side analysts expect that Clorox Co will post 6.08 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.57%. The ex-dividend date is Tuesday, January 23rd. Clorox’s dividend payout ratio is presently 55.45%.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another site, it was illegally copied and republished in violation of international trademark and copyright laws. The correct version of this news story can be read at https://www.watchlistnews.com/clorox-co-clx-shares-bought-by-palladium-partners-llc/1850722.html.

Clorox Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.